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Background: During the acute phase of critical illness myopathy (CIM) there is inexcitability of skeletal muscle.
In a rat model of CIM, muscle inexcitability is due to inactivation of sodium channels. A major contributor to
this sodium channel inactivation is a hyperpolarized shift in the voltage dependence of sodium channel
inactivation. The goal of the current study was to find a biochemical correlate of the hyperpolarized shift in
sodium channel inactivation.
Methods: The rat model of CIM was generated by cutting the sciatic nerve and subsequent injections of
dexamethasone for 7 days. Skeletal muscle membranes were prepared from gastrocnemius muscles, and
purification and biochemical analyses carried out. Immunoprecipitations were performed with a pan-sodium
channel antibody, and the resulting complexes probed in Western blots with various antibodies.
Results: We carried out analyses of sodium channel glycosylation, phosphorylation, and association with other
proteins. Although there was some loss of channel glycosylation in the disease, as assessed by size analysis of
glycosylated and de-glycosylated protein in control and CIM samples, previous work by other investigators suggest
that such loss would most likely shift channel inactivation gating in a depolarizing direction; thus such loss was
viewed as compensatory rather than causative of the disease. A phosphorylation site at serine 487 was identified on
the NaV 1.4 sodium channel α subunit, but there was no clear evidence of altered phosphorylation in the disease.
Co-immunoprecipitation experiments carried out with a pan-sodium channel antibody confirmed that the sodium
channel was associated with proteins of the dystrophin associated protein complex (DAPC). This complex differed
between control and CIM samples. Syntrophin, dystrophin, and plectin associated strongly with sodium channels in
both control and disease conditions, while β-dystroglycan and neuronal nitric oxide synthase (nNOS) associated
strongly with the sodium channel only in CIM. Recording of action potentials revealed that denervated muscle in
mice lacking nNOS was more excitable than control denervated muscle.
Conclusion: Taken together, these data suggest that the conformation/protein association of the sodium channel
complex differs in control and critical illness myopathy muscle membranes; and suggest that nitric oxide signaling
plays a role in development of muscle inexcitability.
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Critical illness myopathy (CIM) is the most common
cause of severe weakness in patients in the intensive
care unit [1,2]. One of the hallmarks of the acute phase
of CIM is paralysis due to loss of muscle’s electrical
excitability [3,4]. To determine the mechanism under-
lying loss of excitability, we utilize a rat model of CIM in
which corticosteroid treatment is combined with denerv-
ation to mimic treatment of critically-ill patients with
corticosteroids and neuromuscular blocking agents [5,6].
In the rat model, inactivation of sodium channels is the
cause of inexcitability [7,8]. A major contributor to the
increase in inactivation is a hyperpolarized shift in
the voltage dependence of inactivation of the adult
(NaV 1.4) and embryonic (NaV 1.5) skeletal muscle so-
dium channel isoforms expressed in CIM muscle [9]. As
the rat model of CIM occurs in genetically normal rats,
this hyperpolarized shift in sodium channel gating must
be due to post-translational modification of sodium
channels or an alteration in sodium channel association
with other proteins that modify gating.
The goal of this study was to identify biochemical
changes that could potentially underlie the hyperpolar-
ized shift in the voltage dependence of sodium channel
inactivation in CIM. We found changes in several candi-
dates, although at least one change appeared compensa-
tory rather than causative. We identified an increase in
the amount of neuronal nitric oxide synthase (nNOS)
associated with the sodium channel in CIM as a change
that might underlie the hyperpolarized shift in the volt-
age dependence of inactivation.Methods
Preparation of control and critical illness myopathy
muscle samples
All animal protocols were approved by the Institutional
Animal Care and Use Committee at Wright State Uni-
versity. Critical illness myopathy was induced by a com-
bination of denervation and dexamethasone treatment.
Briefly, rat muscle was denervated by removing a 10-mm
segment of the sciatic nerve in isoflurane-anesthetized
adult female Wistar rats (250 to 350 g body weight).
Buprenorphine was administered subcutaneously for
postoperative analgesia. Dexamethasone (4 mg kg -1) and
antibiotics (0.2 mL of 2.27% Baytril, Bayer, Shawnee
Mission, KS, USA) were administered intraperitoneally
beginning on the day of denervation and continuing for
7 days. Rats were killed by carbon dioxide inhalation,
and the tibialis anterior, soleus, and gastrocnemius
muscles removed, weighed, and snap-frozen in liquid ni-
trogen. For control muscles, non-treated rats from the
same group were used and muscles harvested in the
same way. All muscles were stored at −80°C until use.Preparation of muscle membranes and classical
purification of sodium channels
Membranes were prepared from the gastrocnemius mus-
cles as previously reported [10]. Samples were thawed
on ice for 10 min and minced finely on a glass plate on
ice. Samples were transferred to tubes containing
sucrose buffer with protease and phosphatase inhibitors,
using 10 volumes of buffer per gram of tissue. The
sucrose buffer contained 0.3 M sucrose, 75 mM NaCl,
10 mM EGTA, 10 mM EDTA, 10 mM Tris, pH 7.4,
1 mM phenylmethylsulfonyl fluoride (PMSF), 1 mM
iodoacetamide, 0.1 μg/mL pepstatin A, 10 μM leupeptin,
2.5 μM ALLN, and 1 mM sodium fluoride. Samples
were homogenized using a PowerGen 700 tissue homo-
genizer at a setting of 6 for 30 s. The samples were cen-
trifuged in a SS34 rotor at 4,500 g for 15 min. The
supernatants were removed and centrifuged again. The
final supernatants were centrifuged in a SW55 rotor at
138,000 g for 1 h. The pellets from this last step were
resuspended in fresh sucrose buffers with inhibitors and
used as the membrane fraction.
For classical purification of sodium channels, mem-
branes were solubilized using NP40 and the sodium chan-
nel fraction sequentially purified on DEAE-Sepharose and
wheat germ agglutinin-Sepharose columns as described
[11]. For all membrane preparation and channel purifica-
tion procedures, samples, equipment, and buffers were
kept at 0-4°C.
SDS-PAGE, western blot analysis, and antibodies
Membrane fractions were assayed for protein content
using the Lowry protein assay, and equal amounts of
protein were loaded for control and CIM samples for
each protein assessed (approximately 40 μg protein
per lane). For deglycosylation experiments and co-
immunoprecipitation experiments, the same amount of
membrane protein was used to initiate the experiment;
and equal volumes of the final product were loaded for
each control and CIM sample analyzed. SDS-PAGE
was performed on Criterion 4% to 20% acrylamide gels
for most samples; but 5% gels were used for the degly-
cosylation experiments, and 10% to 14.5% gels were
used for analysis of syntrophin and β-dystroglycan co-
immunoprecipitations to better resolve the molecular
weight region being analyzed. Western blot transfers
were carried out in a Criterion transfer apparatus
using nitrocellulose as the blotting medium. Following
transfer, blots were washed with PBS/0.1% Tween,
blocked in 1% I-Block (Tropix) in PBS/0.1% Tween for
1 h; incubated with first antibody for 2 h; washed and
incubated with mouse or rabbit secondary antibody
conjugated to alkaline phosphatase (Tropix); and visua-
lized using CDP-Star (Tropix) and a Fujifilm LAS-3000
close-caption device camera.
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raised against the highly conserved peptide, TEEQKKYY-
NAMKKLGSKK, corresponding to SP19 [12] at Open
Biosystems, ThermoFisher Scientific. The affinity-purified
antibody selectively reacted to sodium channel in skeletal
muscle and other tissues and could be displaced by the
peptide antigen in western blot analysis. The antibody
to FGF13 was provided by Dr Geoffrey Pitts (Duke
University). The NaV 1.4-specific monoclonal antibody
was provided by Dr Robert L Barchi (Thomas Jefferson
Medical School), and can be obtained commercially from
Sigma (S9568). Other antibodies were obtained from the
following commercial sources: FGF12 (Abgent AP6750b),
plectin (Epitomics 1399–1), dystrophin (Vector Labs VP-
D508), NaV 1.5 (Alomone ASC-005), nNOS (Invitrogen
37–2800), β-dystroglycan (Abcam ab 49515), and syntro-
phin (Abcam ab11425).
Some gels were stained rather than processed for west-
ern blots. For analysis of phosphoproteins, Peppermint
Stick Phosphoprotein Molecular Weight Standards (Invi-
trogen), which include both phosphoprotein and non-
phosphoprotein standards, were included on the gels as
controls. After electrophoresis, gels were fixed in 50%
methanol and 10% acetic acid for 30 min, transferred to
the Pro-Q Diamond Phosphoprotein Stain (Invitrogen)
for 90 min, then transferred to Destain (Invitrogen) for
30 min. The gel was de-stained twice more for 30 min;
then washed twice in ultrapure water. The gel was
imaged on a flatbed fluorescent scanner (Fujifilm FLA-
5100). After the phosphoprotein stain, the gel was im-
mediately processed for all-protein stain with SYPRO
Ruby Protein Stain (Invitrogen) overnight. The gel was
de-stained with 10% MeOH and 7% acetic acid for
45 min, washed twice in ultrapure water, and imaged on
the fluorescent scanner. The containers with the gels
were covered with foil to prevent photo-bleaching of
the stains.
For proteins that were purified using gels, the gels
were not fixed prior to the SYPRO stain. After the water
wash, these gels were imaged on a UV light-box, their
pictures taken with a digital camera, and the bands of
interest excised and sent to the proteomics facility.
Deglycosylation
For deglycosylation with PNGase F (New England Bio-
labs), 100 μg of control or CIM membranes was adjusted
to 80 uL volume; then 20 uL of 5X denaturation mix
(5 mM PMSF, iodoacetamide, NaF, 12.5 μM ALLN,
0.5 μg/mL pepstatin A, 2.5% SDS, and 0.2 M DTT) was
added and the sample incubated at 65°C for 20 min. Fol-
lowing denaturation and cooling to room temperature,
20 uL of 10% NP40, 20 μL of 500 mM sodium phosphate
(pH 7.5), 59 μL water, and 1 μL (500 units) of PNGase F
were added to each sample and the samples incubated at37°C for 1 h. Samples were quenched by addition of gel
sample buffer. For neuraminidase (New England Biolabs)
treatments, 10 μg of control or CIM membranes were
adjusted to 100 μL with 10 μL of 500 mM sodium citrate
(pH 6.0), 10 μL of 10% NP40, 5 μL neuraminidase
(250 units), and water. Samples were heated at 37°C for
4 h. As a control, 10 μg of fetuin was treated in the same
way. Samples were quenched by addition of gel sample
buffer. For all samples, mock treatments without enzyme
were also carried out. Samples were analyzed by western
blot with NaV 1.4-specific antibody.
Analysis of phosphorylation by tandem mass spec
The mass spectrometric analysis was performed on an
optimized proteomics platform as previously reported
[13]. Briefly, protein gel bands were washed and sub-
jected to standard in-gel trypsin digestion. Digested pep-
tides were analyzed by capillary reverse-phase liquid
chromatography coupled with tandem mass spectrom-
etry (LC-MS/MS), in which the eluted peptides were
analyzed by an MS survey scan followed by 10 data-
dependent MS/MS scans on an LTQ-Orbitrap ion trap
mass spectrometer (Thermo Scientific). Acquired MS/
MS spectra were then searched against the rat reference
database of the National Center for Biotechnology In-
formation with differential modifications on serine/
threonine/tyrosine (+79.9663 Da); then filtered by
matching scores and mass accuracy to reduce protein
false discovery rate to less than 1% using a concatenated
reversed database [14]. Furthermore, we manually vali-
dated MS/MS spectra of matched phosphopeptides using
the following criteria: (1) the presence of signature phos-
phate neutral losses (−49 for doubly charged or −32.7 for
triply charged) for serine/threonine phosphorylation; (2)
the strong intensity (usually the top peak) of the neutral
loss peak; (3) possible ambiguity of modification site
assignment; and (4) comparison of the MS/MS spectra of
modified peptides with the corresponding unmodified
counterparts.
Immunoprecipitation
For each sample analyzed (control, CIM, control/
peptide, CIM/peptide), 200 μL of protein G dynabeads
(Invitrogen) was incubated with 40 μg of pan-NaV 1.x
antibody - and for the peptide controls, 40 μg of block-
ing peptide - for 3 h to 4 h, rotating end-over-end.
During this incubation, 3.0 mg of membrane protein
was prepared for each sample. In a total of 1.8 mL vol-
ume, the sample was solubilized in a buffer containing
20 mM KPO4 (pH 6.5), 180 mM KCl, 1 mM EGTA,
0.5 mM MgCl2, 1 mM PMSF, 1 mM iodoacetamide,
1 mM NaF, 2.5 μM ALLN, 10 μM leupeptin, 0.1 μg/ml
pepstatin A, and 1% NP40. Samples were vortexed, incu-
bated on ice for 1 h, centrifuged at 13,700 x g in a
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recovered for the immunoprecipitation. The antibody-
bound beads were washed twice with PBS/0.5% NP40
and incubated with the solubilized channel protein, ro-
tating end-over-end, overnight. The next morning, the
beads were collected at the side of the tube using a mag-
net, and the supernatants removed. The beads were
washed five times with the same buffer used for
solubilization, except NP40/asolectin was used in the
buffer instead of NP40. The samples were eluted from
the beads with gel sample buffer. Equal volumes of sam-
ple were loaded for each sample (con IP, CIM IP, con IP/
pep, CIM IP/pep), and starting membranes were used
as a positive control (con memb, CIM memb). Six separ-
ate immunoprecipitations were carried out. Prior to elut-
ing with sample buffer, all procedures were maintained
at 0°C to 4°C.
Immunohistochemistry
Medial gastrocnemius muscles from control or CIM rats
were removed, fixed in 4% paraformaldehyde for 1 h,
cryoprotected in 15% sucrose solution overnight, and
frozen in liquid nitrogen. Ten-μm-thick cross-sections
were cut. The same rabbit FGF12 and mouse mono-
clonal nNOS antibodies used in western analysis were
used for staining. For dystrophin staining of the FGF12
samples, the same mouse monoclonal used in western
analysis was used, but for analysis of the mouse nNOS-
stained samples, a rabbit dystrophin was used. Labeling
of mouse monoclonal antibodies was visualized using a
Dylight 488-conjugated donkey anti-mouse secondary
antibody (Jackson ImmunoResearch Laboratories).
Labeling of rabbit antibodies was visualized using a
rhodamine-conjugated donkey anti-rabbit antibody (Jackson
ImmunoResearch Laboratories). Images were obtained
using a Fluoview FV 1000 confocal microscope and an
X60 oil objective (Olympus Optical).
Electrophysiology
Wild type and nNOS knockout adult mice (B6.129 S4-
Nos1tm1Plh /J, Jackson Labs, 25 g to 30 g body weight)
were denervated by removing a 0.5-mm segment of the
left sciatic nerve in the upper thigh under isoflurane
anesthesia (2% to 3% inhaled). Buprenorphine was
administered subcutaneously for postoperative analgesia.
Mice were sacrificed on days 3 or 7 by carbon dioxide
inhalation. The extensor digitorum longus (EDL) muscle
was dissected tendon to tendon; then muscle fibers
were labeled with 10 μM 4-Di-2-ASP, and imaged using
an upright epifluorescence microscope during recording
of action potentials as previously described [8]. For
all experiments, the recording chamber was continu-
ously perfused with solution containing (in millimoles
per liter) NaCl, 118; KCl, 3.5; CaCl2, 1.5; MgSO4, 0.7;NaHCO3, 26.2; NaH2PO4, 1.7; and glucose, 5.5 (pH 7.3-
7.4, 20-22°C) equilibrated with 95% O2 and 5% CO2.
Statistical analysis
Western blots were quantified using the software sup-
plied with the Fujifilm LAS-3000 close-caption device
camera. For western blots with multiple samples of con-
trol and CIM samples (for NaV 1.4, NaV 1.5, pan-NaV 1.x,
FGF12, and FGF13), the average of the control was used
as the 100% standard. All individual control and CIM
samples were calculated relative to this number, and
errors shown are SEM. Statistical comparison between
control and CIM were carried out using Student’s t-test.
For quantification of the co-immunoprecipitation, the CIM
was calculated relative to the control (set at 100%) for
each individual protein in each co-immunoprecipitation.
The expression in CIM relative to control for all six
co-immunoprecipitations was analyzed by Student’s
t-test, and errors shown are SEM. Muscle excitability
was compared by calculating the percent of inexcitable
fibers in each muscle. At least six fibers were studied
in each muscle. The percent for each muscle was
compared between control and nNOS-null mice using
Student’s t-test with n as the number of muscles studied.
Results
CIM skeletal muscle expresses the NaV 1.5 α subunit and
a NaV 1.4 α subunit with altered glycosylation
We utilize a rat model of critical illness myopathy (CIM)
in which corticosteroid treatment is combined with
denervation to mimic treatment of critically-ill patients
with corticosteroids and neuromuscular blocking agents
[5,6]. Previous analysis of mRNA indicated that CIM
skeletal muscle expresses the NaV 1.4 and NaV 1.5
isoforms of sodium channel [15]. To confirm this at the
level of the protein, we analyzed western blots of skeletal
muscle membrane fractions with antibodies specific to
the two channel isoforms (NaV 1.4 and NaV 1.5) and also
with a pan-sodium channel antibody (pan-NaV 1.x) to
compare the amount of both of these isoforms simultan-
eously (Figure 1, A and B). Membranes from heart were
used both as a negative control for the NaV 1.4-specific
antibody and as a positive control for the NaV 1.5 anti-
body. The change in expression observed with each of
these antibodies (Figure 1B) suggests that the increased
expression with the pan-NaV 1.x antibody is due to up-
regulation of the NaV 1.5 and suggests that the NaV 1.5
represents approximately 28% of the total sodium chan-
nel protein in CIM.
While the amount of NaV 1.4 α subunit remained
constant, its migration was altered. One potential
explanation for altered migration of the NaV 1.4 α sub-
unit is an alteration in the level of glycosylation. The
NaV 1.4 α subunit is known to be highly glycosylated
Figure 1 CIM muscle expresses the NaV 1.5 α subunit and a NaV 1.4 α subunit altered in its glycosylation. (A) Western blots were
performed on membranes prepared from gastrocnemius muscles of individual control or CIM rats using antibodies specific to the NaV 1.4 and
1.5 sodium channel isoforms or a pan-NaV 1.x antibody. Heart was a positive control for NaV 1.5. The mobility of the NaV 1.4 changed in CIM
(see the upper arrow to normal channel versus lower arrowhead pointing to altered). It should be noted that 5% gels were used for the blots
with the NaV 1.4 and 1.5 antibodies, while a 4% to 20% gel was used for the NaV 1.x antibody, thus reducing the apparent size difference
between control and CIM for that antibody. (B) Quantification of blots with different sodium channel antibodies. The average expression of
protein under control conditions was set as 100%, and expression in individual control and CIM was calculated relative to this average (n= 4).
Error bars shown are SEM, and asterisks indicate P< 0.01. Since the total amount of NaV 1.4 does not change in CIM, the increase observed with
the pan-NaV 1.x is attributed to the up-regulation of the NaV 1.5. (C) Membranes from control and CIM muscles were treated with either PNGase
F (to remove all N-linked glycosylation) or Neuraminidase (to remove only terminal sialic acid) and visualized by western blotting with a NaV
1.4-specific Ab on 5% gels. Treatment with PNGase F eliminated the migration difference between control and CIM channel, while Neuraminidase
did not. (D) Neuraminidase treatment of fetuin, a control protein that is highly sialyated, shifts the molecular weight, indicating that the enzyme
was functional.
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treated with one of two enzymes, PNGase F, which
removes N-linked glycosylation at the ASN-linkage [18]
or a recombinant neuraminidase, which removes ter-
minal sialic acid moieties [19]. The samples were then
probed in a western blot with the NaV 1.4-specific anti-
body. As shown, removal of the entire carbohydrate
sugar tree at the N-linkage completely abolished migra-
tion differences between the control and CIM samples,
while treatment with neuraminidase did not (Figure 1C).
As a positive control for neuraminidase function, we
treated fetuin (a protein with a large number of sialic
acid moieties), under the same conditions and found a
shift in migration (Figure 1D). Taken together, these data
indicate that a focused removal of terminal sialic acidmoieties is insufficient to account for the change in
migration of NaV 1.4.
Identification of a phosphorylation site in the NaV 1.4
α subunit
In the NaV 1.2 brain sodium channel, a complex inter-
play of phosphorylation of sites within the I-II loop and
the III-IV loop carried out by protein kinase A and C
reduce peak sodium currents [20]. Skeletal muscle
sodium channels are not as highly phosphorylated as
their brain and neuronal counterparts [21], but phos-
phorylation could affect gating of sodium channels in
CIM. NaV 1.4 is phosphorylated by protein kinase A
in vitro at a single site [21]. In the NaV 1.5 channel,
phosphorylation of S1505 in the III-IV loop by protein
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tion gating in the hyperpolarizing direction [22].
As an assessment of the degree of overall phospho-
rylation, classically-purified control and CIM sodium
channels [11] were comparatively stained with Pro-Q
Diamond Phosphoprotein Stain (which stains only phos-
phoproteins) and SYPRO Ruby Protein Stain (which
stains all proteins) (Figure 2A). Quantitative comparison
of the fluorescent signal intensities of the two dyes was
made, and the ratio of Pro-Q to SYPRO was found to
be constant in control versus CIM channel (Figure 2B).
To determine the site at which the phosphorylation
occurred, the sodium channel bands were excised from
control and CIM samples, trypsinized, and analyzed by
tandem mass spectrometry (Figure 3, control sample
shown). The serine at position 487 was partially phos-
phorylated and lies within the general region previouslyFigure 2 The NaV 1.4 is phosphorylated at similar levels in control an
and control muscle, classically-purified sodium channel was stained with a
dye) and the ratio of signal with this stain was compared to that of a dye t
set of proteins that are non-phosphorylated (β-galactosidase, bovine serum
the same gel (P/NP markers). Of these controls, only the ovalbumin stained
each dye. Control and CIM sodium channel, indicated by arrows, had simila
protein stains for each of the experimental and control proteins. The contr
only the ovalbumin standard was phosphorylated.found to contain an in vitro cAMP-phosphorylation site
[21]. However, its surrounding sequence [QALES*GEE]
does not correspond to the conserved consensus
sequence of [RK] 2x [ST] for either cAMP or cGMP-
dependent protein kinase. The lack of a quantitative
difference between the control and CIM channels, based
on the ratio of Pro Q: SYPRO (Figure 2B), suggests that
gross changes in levels of phosphorylation do not under-
lie the shift in voltage dependence of inactivation.
No difference in FGF sub-type associated with CIM
sodium channel
Fibroblast growth factors (FGFs) have emerged as a class
of proteins that modulate sodium channel gating [23-25].
Different FGF isoforms/splice variants shift the inactiva-
tion gating curves of sodium channels to varying degrees,
such that a switch in expression of one sub-type overd CIM muscle. (A) To assess the degree of phosphorylation in CIM
dye that binds only phosphoproteins (Pro Q Diamond phosphoprotein
hat binds all proteins (SYPRO Ruby Red protein stain). As controls, a
albumin) or a known phosphoprotein (ovalbumin) were analyzed on
on both gels, indicating that staining conditions were optimal for
r phosphostaining. (B) Quantification of the ratio of Pro Q: SYPRO









Figure 3 Identification of Ser487 as a phosphorylation site in NaV 1.4 channel. Using previously reported methods [11], a purified fraction of
sodium channels was prepared from control and CIM muscles and the excised band corresponding to the NaV 1.4 α subunit was excised,
trypsinized, and analyzed by tandem mass spectrometry. This analysis indicated that the serine at 487 was partially phosphorylated, as we
detected both the phosphorylated and unmodified forms in the samples. The MS/MS spectra of both forms were shown. The main product ions
(b and y ions) were indicated. It is clear that a number of b ions (b12 and b14) from the two peptides differ in a mass of 80 Da, the mass shift due
to phosphorylation. In addition, neutral loss of phosphorus group was also observed for the modified form. The spectra shown are from a control
sample. Although both control and CIM spectra were partially phosphorylated at the Ser487 site, the exact percentage was difficult to determine
due to the small amount of sodium channel analyzed.
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channel inactivation in CIM [23-25]. Thus, relative expres-
sion of FGFs may be a mechanism through which cells
regulate excitability. Membranes from control and CIM
gastrocnemius muscles were analyzed for expression of
FGF proteins (Figure 4). While we found that neither con-
trol or CIM skeletal muscle expressed FGF 11 and 14
(data not shown), both control and CIM membranes
expressed the same ratio of FGF13 relative to the amount
of total sodium channel protein detected with pan-NaV 1.x
antibody (Figure 4, A and B). In CIM membranes, there
was increased expression of FGF12B relative to the pan-
NaV 1.x antibody (Figure 4, A and B). However, further
analysis of FGF12 localization by staining in muscle cross-
sections indicated the protein was expressed in nuclei, not
the surface membrane, and thus was unlikely to interact
with sodium channels to alter the voltage dependence of
inactivation (Figure 4C). Thus none of the FGFs appear to
be candidates that could account for the hyperpolarized
shift in the voltage dependence of inactivation in CIM.
The sodium channel is part of a protein complex that is
altered in CIM
Work carried out by a number of investigators has
shown that sodium channels are part of the dystrophinassociated protein complex (DAPC) [26,27]. To deter-
mine if the constituent members of this sodium channel
complex are dynamically regulated in CIM, we immuno-
precipitated the complex from control versus CIM
muscle membranes solubilized in the non-ionic deter-
gent NP40. We used the pan-NaV 1.x antibody, directed
towards the highly conserved III-IV linker, to bring
down both the NaV 1.4 and 1.5 isoforms. The recovery
of sodium channel in the immunoprecipitates (IPs)
was specific since a blocking peptide prevented IP of
the sodium channel in both control and CIM samples
(Figure 5). The starting membranes were used as a posi-
tive control. Co-immunoprecipitation (CoIP) of syntro-
phin and dystrophin, the proteins most closely linked to
sodium channel in the complex, was relatively high in
both control and CIM samples (Figure 5B and D). Plec-
tin, which is associated with the sodium channel both
through its interaction with β-dystroglycan and dys-
trophin [28], is present at lower levels in control than
CIM samples. Other proteins (β-dystroglycan and
nNOS) were present primarily in the CIM samples
(Figure 5B and D). A number of CoIPs were carried out
to assess the degree to which proteins were present and
absent in the control versus CIM complexes, such that
statistical significance was reached (Figure 5C). The
Figure 4 FGFs appear unlikely to contribute to altered sodium channel gating in CIM. (A) FGF12 and 13 levels in muscle membrane
samples from control and CIM muscle. As positive controls, tissues or expression vectors known to produce the protein of interest were used: for
the pan-NaV 1.x Ab, skeletal muscle; for FGF13, a lysate of 293 cells transfected with an FGF13 expression vector; for FGF12, brain membranes.
(B) FGF13 was expressed in both control and CIM muscle, such that the relative ratio of FGF13: sodium channel did not change in CIM. In
contrast, FGF12B was expressed at low levels in control muscle, but increased in CIM muscle, such that the ratio of FGF12B: sodium channel
significantly increased. Asterisk indicates P< 0.05. (C) Cross-section of control and CIM medial gastrocnemius muscle stained for FGF12, dystrophin,
and overlay reveals that most FGF12 staining is in myonuclei and nuclei of cells in the interstitial space.
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(Figure 5D), in that β-dystroglycan and nNOS, shown in
white, are primarily associated with CIM sodium channels.
In other models of muscle atrophy, nNOS was reported
to move from the surface membrane to an intracellular
pool [29]. To confirm that nNOS is co-localized with
sodium channel in the surface membrane in the CIM
muscle, cross-sections of CIM muscle were stained for
nNOS using dystrophin as a marker for the surface mem-
brane (Figure 6). Both control and CIM surface mem-
brane were positive for nNOS (Figure 6). Taken together,
the biochemical and immunostaining data indicate that
nNOS is a dynamically regulated member of the sodium
channel-DAPC complex.
nNOS plays a role in loss of muscle excitability
following denervation
In the rat model of CIM, treatment of denervated
muscle with corticosteroids in vivo results in inexcitabil-
ity of muscle fibers [7,8,30]. The biochemical data pre-
sented above are consistent with the possibility that
increased association of nNOS with sodium channelscontributes to loss of excitability. To determine the role
of nNOS in regulation of muscle excitability following
denervation, we recorded from muscle fibers in nNOS-
null and control mice. In innervated mouse muscle,
100% of fibers were excitable (n= 4 muscles). We found
that denervation of mouse muscle in the absence of
treatment with corticosteroids was sufficient to induce
inexcitability. In control muscle denervated for 3 days,
few muscle fibers were excitable (n= 4 muscles, Figure 7).
In contrast, in nNOS-null mice the majority of fibers
remained excitable 3 days after denervation (n= 4 mus-
cles, P < 0.05 vs. control). To determine whether absence
of nNOS lessened development of inexcitability at a
longer time point, we measured excitability in a second
set of mice in which muscle was denervated for 7 days.
In control muscle, no fibers remained excitable 7 days
following denervation (n= 4 muscles); whereas in nNOS-
null fibers, excitability was preserved in a fraction of
fibers (n= 4 muscles, P< 0.05 vs. control). These data are
consistent with the possibility that increased association
of nNOS with sodium channels following denervation
contributes to development of muscle inexcitability.
Figure 5 NaV 1.4 co-precipitates with members of the dystrophin associated protein complex (DAPC). Using an antibody generated
against a peptide corresponding to the highly conserved III-IV linker region (pan NaV 1.x), sodium channels from NP40-solubilized control and CIM
skeletal muscle membranes were immunoprecipitated. The immunoprecipitated (IP) control (Con) or CIM materials were resolved on SDS-PAGE
gels and probed in western blots with the indicated antibodies. As a negative control, the IP was performed in the presence of blocking
peptide (IP/pep), the same sequence used as the antigen; and as a positive control, starting membranes were used (Memb). (A) A full-panel
western with the NaV 1.4-specific monoclonal antibody LD3 is shown on the left in comparison to a protein gel stained with SYPRO Ruby
protein stain on the right. The denatured antibody heavy chain (Ab HC) and light chain (Ab LC) are present in the immunoprecipitated samples,
as best seen in the SYPRO stained gel. A large number of proteins co-precipitate with the sodium channel (NaV 1.x), and many of these are
shown to be specific since they are absent in the peptide control. (B) Using antibodies against plectin, dystrophin (dys), neuronal nitric oxide
synthase (nNOS), syntrophin (syn), and β-dystroglycan (β-dys) confirms that many components of the DAPC are present in the control and CIM
IPs. (C) Quantification of the data from panel B. For each antibody in each CoIP, the signal for the control was set as 100% and the signal for the
CIM was determined relative to this. The average of the signals for the CIM: control for each antibody is shown, and error bars are SEM (n =6).
For some antibodies, notably the sodium channel antibodies, approximately equal signals were seen in control and CIM CoIPs. For other
antibodies, notably dystrophin and syntrophin, there were slightly elevated amounts of these proteins present in the CIM. Finally, for the nNOS
and β-dystroglycan, there was considerably more protein in the CIM CoIPs. These results are summarized in cartoon form in (D) which shows
‘tightly’ associated proteins in grey, and ‘loosely’ associated proteins in white. The protein associations shown in the cartoon are based on work
carried out by a number of investigators, which previously demonstrated that NaV 1.x channels associate with proteins of the DAPC through their
consensus S/TXV-COOH C-termini [26,27]. The dynamic regulation of the signaling protein nNOS in CIM suggests that it may play a role in the
disease process, including affecting the inactivation gating of the adjacent sodium channels.
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Figure 6 nNOS is expressed in the sarcolemma of control and CIM muscle. Cross-sections of medial gastrocnemius muscle were stained
with the antibodies to nNOS as well as dystrophin to mark muscle surface membrane. In both control and CIM, nNOS is expressed in the surface
membrane. The myofiber cross-sections are much smaller in CIM muscle, due to the previously reported muscle atrophy in the disease [10].
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We compared biochemical properties of control and
CIM sodium channels to find candidates that might ac-
count for the hyperpolarized shift in inactivation gating
seen in the acute phase of CIM. We identified several
biochemical changes in sodium channel in CIM, but the
most promising candidates appeared to be alterations in
sodium channel-associated proteins in CIM. In particu-
lar, nNOS is a promising candidate that was more asso-
ciated with sodium channels from CIM muscle. In mice
lacking nNOS, the normal reduction in excitability fol-
lowing denervation was greatly reduced. These data are
consistent with the possibility that increased association
of nNOS with sodium channels is involved in triggering
loss of muscle excitability in CIM.
We identified an increase in NaV 1.5 in CIM muscle
such that it is approximately 28% of the entire channel
population. This is similar to our earlier estimate of 21%
obtained by measuring current densities [9]. In our pre-
vious study, both the TTX-insensitive (NaV 1.5) and
TTX-sensitive (NaV 1.4) channels demonstrated similar
hyperpolarizing shifts in inactivation gating in CIM [9],
so increased expression of NaV 1.5 per se cannot be
responsible for the shift.
A second change identified in membranes from CIM
muscle was reduced glycosylation of the NaV 1.4 sodium
channel. Removal of the entire carbohydrate ‘tree’ at
the asparagine-linkage eliminated the molecular weight
difference between the control and CIM channel. How-
ever, selective removal of sialic acid moieties withneuraminidase did not eliminate the size difference.
Given that the NaV 1.4 channel is known to have mul-
tiple carbohydrate trees [16,17], the simplest explanation
for these observations is that some but not most of the
carbohydrate trees are removed in CIM, removing some
but not most of the sialic acids. Previous work shows
that removal of sialic acid from sodium channels shifts
inactivation gating in a depolarizing direction [16,17,31].
This is opposite of the hyperpolarizing shift we observed
in CIM [9]. Thus, removal of some carbohydrate trees
may be a compensatory mechanism that moves the volt-
age dependence of inactivation towards more depolar-
ized potentials.
One change we found in CIM muscle that could
underlie the hyperpolarized shift in the voltage depend-
ence of inactivation was an alteration in the composition
of the dystrophin protein associated complex (DAPC) as
summarized in Figure 5D. This figure is based not only
on work in this paper, but also on work carried out by
other investigators that identified the components of the
DAPC (reviewed in [32]). In our hands, the DAPC
appeared to dissociate more easily in control samples
such that all components (except sodium channels) were
present at higher levels in the CIM samples. This was es-
pecially true for β-dystroglycan and nNOS, which are
present at much higher levels in CIM CoIPs. These
observations suggested to us that the sodium channel-
DAPC complex is bound more tightly in CIM, perhaps
indicating that the sodium channel and cytoskeleton are
in a different and more strongly ‘locked’ conformation in
Figure 7 Muscle lacking nNOS is more excitable following
denervation. (A) Action potential traces from innervated and
denervated wild-type and nNOS (NOS-1) null fibers. In innervated
wild-type and nNOS null fibers, all or none action potentials are
present. In the control 3 and 7 day denervated traces shown, no
action potential is present and the only response is passive
depolarization of the membrane potential in response to current
injection. In the 3-day denervated nNOS null fiber shown a nearly
normal action potential is present. In the 7-day denervated nNOS
null fiber shown an action potential is present, but it is smaller and
wider than action potentials from innervated muscle. (B) Plot of the
percent of excitable fibers in innervated and denervated wild-type
and nNOS null fibers. In both wild-type and nNOS null innervated
muscles 100% of fibers were excitable in all muscles studied (n= 4
for wild-type, n= 3 for nNOS null). Three days following denervation
only 13% of fibers were excitable in wild type muscles (n= 4). In
nNOS null muscles 73% of fibers were excitable 3 days following
denervation (P< 0.05 vs. wild-type, n= 4). Seven days following
denervation 0% of wild-type fibers were excitable (n= 4) while
43% of fibers from nNOS null muscles were excitable (P< 0.05 vs.
wild-type, n= 4).
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the DAPC may be dynamically regulated. In either case,
the presence of the important signaling protein nNOS in
the DAPC of CIM muscle suggests that NO signaling
through this protein could contribute to the altered
inactivation gating in CIM.The protein components that we identified in the
DAPC are consistent with those identified by other
investigators [26,27]. In skeletal muscle, the consensus
C-termini (S/TXV-COOH) of NaV 1.4 and 1.5 sodium
channels bind the PDZ domain of syntrophin at a site
overlapping and/or closely adjacent to the binding site
for nNOS [26]. Through syntrophin, both sodium chan-
nels and nNOS bind the C-terminus of dystrophin [26].
In cardiac muscle, the dynamic nature of this complex
was shown by comparative analysis of control vs. syntro-
phin point mutation that causes Long QT syndrome.
The syntrophin point mutation altered the complex con-
stituents, such that the plasma membrane Ca2+ ATPase
no longer bound syntrophin. This released inhibition of
nNOS, allowed S-nitrosylation of the NaV 1.5 sodium
channel, and altered gating [27].
Dystrophin is part of the muscle cytoskeletal system.
In mdx mice, which lack dystrophin, sodium channel in-
activation gating is shifted 10 mV more positively than
that of control mice [33]. This observation suggests that
loss of cytoskeletal components shifts inactivation gating
in a depolarizing direction, a finding consistent with our
hypothesis that sodium channel inactivation gating is
hyperpolarized in CIM because it is more tightly asso-
ciated with cytoskeletal components. However, acute dis-
ruption of cytoskeleton by pressure during formation of
seals during patch clamp measurements has been found
to trigger hyperpolarized shifts in the voltage dependent
of NaV 1.4 and NaV 1.5 activation and fast inactivation
[34-37]. Thus, while it is clear that changes in cytoskel-
eton can have profound effects on the voltage depend-
ence of sodium channel gating, we currently do not
know which changes in cytoskeleton will translate into
changes in sodium channel gating.
Our finding that nNOS is present at higher levels in the
sodium channel-DAPC complex in CIM raises the possi-
bility that increased signaling through NO-dependent
pathways contributes to loss of muscle excitability in CIM
(see however, [38]). There are several cell signaling path-
ways that are regulated by NO, including protein phos-
phorylation through cGMP-protein kinase [39] and direct
nitrosylation of cysteine or other amino acid side chains,
as discussed above for the cardiac NaV 1.5 [27]. We mea-
sured phosphorylation changes in CIM and found no
overall difference (Figure 2).
To determine whether increased association of nNOS
with sodium channels could be involved in inducing
inexcitability of muscle, we measured excitability follow-
ing denervation in control and nNOS-null mice. In rats,
denervation alone induces inexcitability in only a minor-
ity of fibers, so addition of corticosteroids is necessary
to induce inexcitability [8,30]. In control mice, denerv-
ation alone was sufficient to induce inexcitability so it
was not necessary to co-administer corticosteroids. In
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remained excitable following denervation. There are
multiple mechanisms that could account for mainten-
ance of excitability following denervation in the absence
of nNOS. Further study will be necessary to determine
if the contribution of nNOS to inexcitability is mediated
by its association with sodium channels as part of
the DAPC.
Conclusion
We surveyed sodium channels and their associated pro-
teins in control versus CIM muscle using a variety of
biochemical techniques to identify candidates that could
underlie the hyperpolarized shift in inactivation gating/
loss of electrical excitability that is characteristic of CIM.
While we identified a number of changes in CIM,
including increased expression of the NaV 1.5 sodium
channel and partial de-glycosylation of the NaV 1.4
sodium channel, it is the change in association of the
sodium channels with members of the DAPC that seems
most promising as a potential explanation for the shift
in inactivation.
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